PL357179A1 - Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers - Google Patents

Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers

Info

Publication number
PL357179A1
PL357179A1 PL01357179A PL35717901A PL357179A1 PL 357179 A1 PL357179 A1 PL 357179A1 PL 01357179 A PL01357179 A PL 01357179A PL 35717901 A PL35717901 A PL 35717901A PL 357179 A1 PL357179 A1 PL 357179A1
Authority
PL
Poland
Prior art keywords
mtdc
methyl
dicarboxylic acid
thiazolidin
treating
Prior art date
Application number
PL01357179A
Other languages
English (en)
Polish (pl)
Inventor
Rudy Susilo
Original Assignee
Rudy Susilo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rudy Susilo filed Critical Rudy Susilo
Publication of PL357179A1 publication Critical patent/PL357179A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01357179A 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers PL357179A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
PCT/DE2001/000656 WO2001060343A2 (de) 2000-02-15 2001-02-15 Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
PL357179A1 true PL357179A1 (en) 2004-07-26

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01357179A PL357179A1 (en) 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers

Country Status (15)

Country Link
US (2) US6943185B2 (enExample)
EP (1) EP1255538B1 (enExample)
JP (1) JP2003522782A (enExample)
CN (1) CN1400899A (enExample)
AT (1) ATE252383T1 (enExample)
AU (1) AU783933B2 (enExample)
CA (1) CA2399709C (enExample)
DE (2) DE10008159B4 (enExample)
EA (1) EA004592B1 (enExample)
ES (1) ES2208571T3 (enExample)
MX (1) MXPA02007903A (enExample)
PL (1) PL357179A1 (enExample)
PT (1) PT1255538E (enExample)
TR (1) TR200302134T4 (enExample)
WO (1) WO2001060343A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
CN101838218A (zh) * 2002-02-28 2010-09-22 日本烟草产业株式会社 酯化合物及其医药用途
WO2005021486A1 (ja) * 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
AU2005297923B2 (en) * 2004-10-25 2010-12-23 Japan Tobacco Inc. Solid medicinal preparation improved in solubility and stability and process for producing the same
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Also Published As

Publication number Publication date
ATE252383T1 (de) 2003-11-15
EP1255538A2 (de) 2002-11-13
AU783933B2 (en) 2005-12-22
PT1255538E (pt) 2004-03-31
EA004592B1 (ru) 2004-06-24
DE50100833D1 (de) 2003-11-27
DE10008159A1 (de) 2001-09-06
MXPA02007903A (es) 2004-09-10
EA200200853A1 (ru) 2003-02-27
DE10008159B4 (de) 2005-08-18
US20050187271A1 (en) 2005-08-25
EP1255538B1 (de) 2003-10-22
CN1400899A (zh) 2003-03-05
WO2001060343A3 (de) 2002-05-30
TR200302134T4 (tr) 2004-01-21
ES2208571T3 (es) 2004-06-16
WO2001060343A2 (de) 2001-08-23
AU3919001A (en) 2001-08-27
US6943185B2 (en) 2005-09-13
US20030149085A1 (en) 2003-08-07
JP2003522782A (ja) 2003-07-29
CA2399709A1 (en) 2001-08-23
CA2399709C (en) 2007-05-15

Similar Documents

Publication Publication Date Title
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
WO2002076499A3 (en) Combination treatment of pancreatic cancer
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
GEP20063934B (en) Methods of treatment of a bcl-2 disorder
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
MXPA03007140A (es) Derivados de carbolina.
IL152754A0 (en) Quinazoline derivatives for the treatment of tumours
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
HK1047707A1 (zh) (+)-曲马朵、o-去甲曲马朵或(+)-o-去甲曲马朵、o-去甲-n-单-去甲-曲马朵或(+)-o-去甲-n-单-去甲-曲马朵治疗尿失禁的用途
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
ZA200004363B (en) Treatment or prevention of coccidiosis.
ZA200203166B (en) Treatment of cancer.
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
IL164356A (en) Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer
ZA981558B (en) Inclusion complexes in aqueous solution

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)